Here we explore the adaptive immune landscape of MDA5+ DM by comprehensive single-cell studies, including single-cell RNA sequencing (scRNA-seq) and B/T cell receptor sequencing (scBCR/TCR-seq) in MDA5+ DM patients, as well as IIM disease and healthy controls. This evidence concerns the gene IFIH1 and dermatomyositis.